北京瑞博奥医药科技有限公司

北京瑞博奥医药科技有限公司

北京市北京

一、企业概况：宁夏蓝博思化学技术有限公司成立于2016年3月，公司坐落于宁夏省级化工园区-宁夏平罗医药产业园，生产范围为化学药品原料药、医药中间体的研发、生产和销售。公司严格按照美国FDA、欧盟、中国GMP标准，设计并建成标准的现代化厂房与先进的原料药生产线，并建有完善的质量管理体系，加强现场安全和环境管理，确保产品质量，不断提高质量管理水平，将公司打造为一座现代化高端原料药生产基地。经营思想：生产高品质的产品；以创新为行业发展做努力。我们希望将来不仅是特色高端原料药制造商，更是值得客户和社会信赖的合作伙伴。 二、项目基本情况：本项目计划总投资约1.2亿元，占地52亩，建筑面积20716平米，建设内容有：研发楼、创新药中试研究基地、抗病毒原料药生产车间、原料仓库、成品仓库、智能控制中心和公用工程间、储罐区、高低压配电室、空压站、污水处理站、消防水池、循环水池、事故池、消防泵房等配套公用设施。项目投产后将实现年产广谱抗病毒药物（Triazavirine）中间体 60吨，高精氨酸1吨、氟罗地尔原料药3吨。 三、项目建成后经济社会效益：项目一期达产后，预计每年可实现销售收入4亿元，销售税金及附加0.7亿元。项目二期达产后，可实现销售20亿左右。 四、进展情况：项目建设已完成，设备安装调试完毕，进入试生产环节。  

102600

3-O-Benzyl-4-C-Hydroxymethyl-1,2-O-Isopropylidene-α-D-Ribofuranose（63593-03-3）;1,2-O-(1-methylethylidene)-4-C-[(phenylmethoxy)methyl]-3-O-(phenylmethyl)-β-L-Lyxofuranose（153186-10-8）;2'-deoxy-4'-C-ethynyl-2-fluoroadenosine（865363-93-5）;D-erythro-Pentitol, 1,4-anhydro-3-O-[bis(4-methoxyphenyl)phenylmethyl]-2-deoxy-, 2-cyanoethyl bis(1-methylethyl)phosphoramidite（401813-16-9）;Adenosine, N-benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-deoxy-2'-fluoro, 3'-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite]（136834-22-5）;Guanosine, 5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-deoxy-2'-fluoro-N-(2-methyl-1-oxopropyl)-, 3'-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite]（144089-97-4）;Cytidine, N-acetyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-deoxy-2'-fluoro-, 3'-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite]（159414-99-0）;Uridine, 5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-deoxy-2'-fluoro-, 3'-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite]（146954-75-8）;Adenosine, N-benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-O-methyl-, 3'-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite]（110782-31-5）;Guanosine, 5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-O-methyl-N-(2-methyl-1-oxopropyl)-, 3'-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite]（150780-67-9）;Cytidine, N-acetyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-O-methyl-, 3'-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite]（199593-09-4）;Uridine, 5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-O-methyl-, 3'-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite]（110764-79-9）;Adenosine, N-benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-deoxy-, 3'-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite]（98796-53-3）;Cytidine, N-acetyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-deoxy-5-methyl-, 3'-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite]（105931-57-5）;Guanosine, 5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-deoxy-N-(2-methyl-1-oxopropyl)-, 3'-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite]（93183-15-4）;Uridine, 5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-deoxy-5-methyl-, 3'-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite]（98796-51-1）;Uridine,5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-O-[(1,1-dimethylethyl)dimethylsilyl]-3'-[2-Cyanoethyl N,N-bis (1-methylethyl)phosphoramidite]（118362-03-1）;Adenosine, 5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-O-[(1,1-dimethylethyl) dimethylsilyl]-N-benzoyl-3'-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite]（104992-55-4）;Cytidine, 5′-O-[bis(4-methoxyphenyl)phenylmethyl]-2′-O-[(1,1-dimethylethyl)dimethylsilyl]- N-benzoyl-3′-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite]（118380-84-0）;Cytidine, 5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-O-[(1,1-dimethylethyl) dimethylsilyl]- N-acetyl-3'-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite]（121058-88-6）;Guanosine, 5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-O-[(1,1-dimethylethyl)dimethylsilyl]-N-isobutyryl-3'-[2-cyanoethyl-N,N- bis(1-methylethyl)phosphoramidite]（147201-04-5）;N6-benzoyl-5'-(4,4'-dimethoxytrityl)-2'-benzoyl-2',3'-seco-adenosine-3'-cyanoethyl Phosphoramidite（1120329-52-3）;Phosphoramidous acid, N,N-bis(1-methylethyl)-, (2R)-2-[(1R)-1-[4-(acetylamino)-2-oxo-1(2H)-pyrimidinyl]-2-(benzoyloxy)ethoxy]-3-[bis(4-methoxyphenyl)phenylmethoxy]propyl 2-cyanoethyl ester（1120329-56-7）;Phosphoramidous acid, N,N-bis(1-methylethyl)-, (2R)-2-[(1R)-2-(benzoyloxy)-1-[1,6-dihydro-2-[(2-methyl-1-oxopropyl)amino]-6-oxo-9H-purin-9-yl]ethoxy]-3-[bis(4-methoxyphenyl)phenylmethoxy]propyl 2-cyanoethyl ester（1120329-61-4）;Phosphoramidous acid, N,N-bis(1-methylethyl)-, (2R)-2-[(1R)-2-(benzoyloxy)-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)ethoxy]-3-[bis(4-methoxyphenyl)phenylmethoxy]propyl 2-cyanoethyl ester（1120329-48-7）;N6-Bz-2'-O-4'-C-Locked-Ar-CE-Phosphoramidite; N6-benzoyl-5'-O-(4, 4'-dimethoxytrityl)-2'-O-4'-C-Locked-adenosine-3'-cyanoethyl Phosphoramidite（206055-79-0）;N4-benzoyl-5-methyl-5'-O-(4, 4'-dimethoxytrityl)-2'-O-4'-C-Locked-cytidine-3'-cyanoethyl Phosphoramidite（206055-82-5）;N2-isobutyryl-5'-O-(4, 4'-dimethoxytrityl)-2'-O-4'-C-Locked-Guanosine-3'-cyanoethyl Phosphoramidite（206055-77-8）;5'-O-(4, 4'-dimethoxytrityl)-2'-O-4'-C-Locked-thymidine-3'-cyanoethyl Phosphoramidite（206055-75-6）;Adenosine, N-benzoyl-5′-O-[bis(4-methoxyphenyl)phenylmethyl]-2′-O-2-propyn-1-yl-, 3′-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite]（171486-59-2）;Uridine, 5′-O-[bis(4-methoxyphenyl)phenylmethyl]-2′-O-2-propyn-1-yl-, 3′-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite]（171486-62-7）;L96;5’-Biotin CE Phosphoramidite（135137-87-0/1807503-79-2);Chemical phosphorylation reagent(108783-02-4);Cholesterol Labeling(143723-64-2);5’-Amino-Modifier C6-MMTr CE Phosphoramidite(114616-27-2);5’-Amino-Modifier C6-TFA CE Phosphoramidite(133975-85-6);Thiol-Modifier C6 S-S CE Phosphoramidite(148254-21-1);6’-Heptanyne CE Phosphoramidite(1438277-11-2);P-reagent(102691-36-1);di-DMTr-Glycerol CE Phosphoramidite(125922-95-4);2′-Pivaloyloxymethyl-N6-Bz-adenosine(2842847-62-3);Guanosine, N-(2-methyl-1-oxopropyl)-, 2′,3′-bis(2-methylpropanoate)(56489-75-9);Bis(2-cyano-1,1-dimethylethyl) N,N-bis(1-methylethyl)phosphoramidite(916996-01-5);Methyl N,N,N′,N′-tetrakis(1-methylethyl)phosphorodiamidite(92611-10-4);2-Propen-1-yl N,N,N′,N′-tetrakis(1-methylethyl)phosphorodiamidite(108554-72-9);N6-Benzoyl-2'-O,4'-C-Methylene-β-D-adenosine (209968-94-5);N4-Benzoyl-2’-O,4’-C-methylene-β-D-cytidine (221229-74-9);N-[(dimethylamino)methylene]-2'-O,4'-C-methylene-β-D-guanosine (1152762-57-6);1-(2'-O,4'-C-methylene-β-D-ribofuranosyl)thymidine (206055-67-6);2'-O,4'-C-methylene-β-D-uridine (200435-92-3);N4-Benzoyl-5-methyl-2'-O,4'-C-methylenecytidine (206055-81-4);2'-O-(2-methoxyethyl)guanosine (473278-54-5);2’-O-(2-methoxyethyl)adenosine (168427-74-5);2’-O-(2-methoxyethyl)cytidine (223777-16-0);2’-O-(2-methoxyethyl)uridine (223777-15-9);2'-deoxy-2'-fluorouridine (784-71-4);2'-deoxy-2'-fluorocytidine (10212-20-1);2'-deoxy-2'-fluoroguanosine (78842-13-4);2'-deoxy-2'-fluoroadenosine (64183-27-3);Pseudouridine (1445-07-4);2'-O-methylguanosine (2140-71-8);2’-O-methyladenosine (2140-79-6);2’-O-methylcytidine (2140-72-9);2’-O-methyluridine (2140-76-3);2,2'-Cyclouridine (3736-77-4);Cedazuridine (1141397-80-9);N-benzoyl-2'-deoxy-2'-fluoroadenosine (136834-20-3);2'-deoxy-2'-fluoro-N-(2-methyl-1-oxopropyl)guanosine (80681-25-0);N-acetyl-2'-deoxy-2'-fluorocytidine (159414-97-8);N-benzoyl-2'-O-methyladenosine (85079-00-1);2'-O-methyl-N-(2-methyl-1-oxopropyl)guanosine (63264-29-9);N-acetyl-2'-O-methylcytidine (113886-71-8);2’-Deoxyadenosine monohydrate (16373-93-6);2’-Deoxyguanosine monohydrate (312693-72-4);2’-Deoxyinosine (890-38-0);2’-Deoxyuridine (951-78-0);5-Fluoro-2’-deoxyuridine (50-91-9);5-Iodo-2’-deoxyuridine (54-42-2);7-Deaza-2’-deoxy-D-guanosine (86392-75-8);3’-Deoxy-adenosine (cordycepin) (73-03-0);4'-Azidocytidine (478182-28-4);3'-deoxy-3'-fluorouridine (57944-13-5);2'-C-Methyluridine (31448-54-1);1-(2-Deoxy-2-fluoro-β-D-arabinofuranosyl)uracil (69123-94-0);2-N-(phenylacetyl)-9-(β-D-ribofuranosyl)-guanine (132628-16-1);3'-deoxy-3'-fluoroguanosine (123402-21-1);2'-deoxy-5-(hydroxymethyl)uridine (5116-24-5);2'-deoxy-5-(hydroxyethyl)uridine (90301-60-3);2'-deoxy-5-(3-hydroxypropyl)uridine (97974-98-6);7-Deaza-2'-Deoxyadenosine (60129-59-1);8-Aza-7-Deaza-2'-Deoxyadenosine (17318-21-7);8-Aza-7-Deaza-2'-Deoxy-7-Iodoadenosine (187479-00-1);8-Aza-7-Bromo-7-Deaza-2'-Deoxyadenosine (200066-12-2);8-Aza-7-Deaza-2'-Deoxyguanosine (100644-70-0);8-Aza-7-Deaza-2'-Deoxy-7-iodoguanosine (183274-53-5);5’-deoxy-5-fluorouridine (doxifluridine) (3094-09-5);3'-O-methylguanosine (10300-27-3);1,2,3-tri-O-acetyl-5-deoxy-β-D-ribofuranose (62211-93-2);2-Deoxy-D-Ribose (533-67-5);2,3,5-Tri-O-benzyl-D-ribono-1,4-lactone (55094-52-5);2-C-Methyl-D-ribono-1,4-lactone (492-30-8);1,2,3,5-Tetra-O-benzoyl-2-C-methyl-β-D-ribofuranose (15397-15-6);L-Ribose (24259-59-4);1,2,3,5-tetra-O-acetyl-β-L-ribofuranose (144490-03-9);1-acetyl-23,5-tri-O-benzoyl-β-L-ribose (3080-30-6);1,2,3-triacetyl-5-deoxy-L-ribosen (193526-80-6);1,2:5,6-di-O-isopropylidene-α-D-glucofuranose (582-52-5);Methyl β-D-glucopyranoside (709-50-2);2,3,4,6-Tetra-O-benzyl-D-glucopyranose (4132-28-9);1,2:5,6-Di-O-isopropylidene-alpha-D-allofuranose (2595-05-3);1,2:5,6-di-O-isopropylidene-3-O-benzyl-α-D-allofuranose (22331-21-1);1,3,4,6-tetra-O-acetyl-β-D-mannopyranose (18968-05-3);Isopropyl β-D-thiogalactoside (IPTG)(367-93-1);Methyl 2,3,4,6-tetra-O-benzyl-α-D-glucopyranoside (53008-63-2);2,3,4,6-tetra-O-benzyl-D-galactopyranose (53081-25-7);2-nitrophenyl β-D-galactopyranoside (ONPG)(369-07-3);2,3-O-isopropylidene-D-ribonic-γ-lactone (30725-00-9);4-nitrophenyl-β-D-galactopyranoside (PNPG)(3150-24-1);L-Xylose (609-06-3);L-Fucose (2438-80-4);α-D-Glucopyranuronic acid, methyl ester, 2,3,4-tris(2,2-dimethylpropanoate) (86448-97-7);n-octyl β-D-glucopyranoside (29836-26-8);Decyl-β-D-glucopyranoside (58846-77-8);2-Deoxy-D-glucose (154-17-6);1,3,5-tri-O-benzoyl-2-deoxy-2-fluoro-α-D-arabinofuranose (97614-43-2);1-O-acetyl-2,3.5-tri-O-benzoyl-β-D-Ribofuranose (6974-32-9);1-Chloro-2-deoxy-3,5-di-O-toluoyl-L-ribofuranose (141846-57-3);2-Deoxy-L-Ribose (18546-37-7);1-Chloro-3,5-di-O-(4-chlorobenzoyl)-2-deoxy-D-ribofuranose (21740-23-8 /3601-90-9);1-Chloro-3,5-di-O-toluoyl-2-deoxy-D-ribofuranose (3601-89-6);1,2-Dideoxy-D-Ribose (91547-59-0);β-Nicotinamide mononucleotide (NMN) (1094-61-7);Nicotinamide riboside chloride (NRCl) (23111-00-4)

第二十三届世界制药原料中国展

2025-03-06至2025-07-31

W6B76

Intermediates & Fine Chemicals